Merck, Samsung Bioepis roll out Herceptin biosimilarOntruzant will be available at a 15% discount to the current list price of Herceptin, the company said. Alembic launches generic ZithromaxAlembic’s azithromycin tablets are available in dosage strengths of 250 mg and 500 mg. Zydus gets FDA nod for generic Gleevec, tentative OK for generic Jardiance Zydus Cadila's generic Gleevec, and generic Jardiance will both be available in two dosage strengths. Zydus Cadila gets FDA OK for Baclofen Zydus Cadila's baclofen tablets are available in a dosage strength of 5 mg. FDA gives tentative nod for Alembic's generic Lastacaft Alcaftadine ophthalmic solution has a market value of roughly $7 million for the 12 months ended December 2019, according to IQVIA. Zydus gets tentative OK for generic Opsumit Generic Opsumit tablets will be available in a dosage strength of 10 mg. Amneal launches generic Butrans Butrans had a market value of roughly $225 million for the 12 months ended February 2020, according to IQVIA. Mylan's Robert Coury returns as executive chairman Robert Coury returns to Mylan as executive chairman amid the COVID-19 outbreak, and activities needed to close the combination of Mylan and Upjohn. Dr. Reddy's rolls out 2 generics For the year ended January 2020, Nitroglycerin transdermal patch products had a market value of roughly $14.7 million, and the Evekeo brand and generic had a market value of approximately $38 million. Cipla obtains FDA approval for generic Proventil HFA Cipla’s generic albuterol inhaler is the first generic to treat and prevent bronchospasm. First Previous 143 144 145 146 147 Next Last